Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.
The Las Vegas Sphere is currently adorned with the cartoon creatures of crypto-native brand Pudgy Penguins. Here's how it ...